Europe Vitamin D Testing Market Presents Strong, Untapped Potential for Growth

Published Date : Jan 06, 2016

Albany, New York, Jan 06, 2016: An estimated 70.0% of the total population in Europe suffers from the deficiency of vitamin D and a measly 5-6% of those people have undergone vitamin D testing. This suggests that the Europe vitamin D testing market has significant potential for growth, given its large patient pool. A report recently added to the vast repository of studies the vitamin D testing market in Europe and provides readers with a clear understanding of the workings of the regional market and the various factors that drive it. The 63-page report is titled “Vitamin D Testing Market in Europe - Industry Analysis 2015-2019” and also offers readers an overview of the limitations, adoption, and opportunities of the vitamin D testing market.

The deficiency of vitamin D can result in several chronic ailments and diseases such as asthma and cancer and if not detected and treated at an early stage, can prove to be fatal for the patient. This is one of the most important factors driving the demand for vitamin D testing in Europe. According to the report, the vitamin D testing market in Europe is projected to expand at a CAGR of over 5.0% from 2015 to 2019.

The vitamin D testing market can be segmented into two main categories based on application: 1, 25-dihydroxy vitamin D test and 25-hydroxy vitamin D test. In 2014, 25-hydroxy vitamin D test emerged as the strongest segment, accounting for 77.0% of the overall market in Europe. This is the most common test used to detect the level of vitamin D in the body and the segment is projected to retain its lead throughout the forecast period.

For Sample Copy, click here:

From the vendors’ perspective, the Europe vitamin D testing market appears immensely lucrative since a large portion of the market is still untapped. As a result, the competition among the players is quite intense as each company is focused on developing products that have higher efficiency and accuracy. Constant investment in innovation and research and development is a key strategy adopted by some of the players.

The top vendors evaluated in the Europe vitamin D testing market include Siemens Healthcare, DiaSorin, Fujirebio Diagnostics, bioMérieux, Roche Diagnostics, and Abbott Diagnostics. The report also features a host of other leading players operating in the vitamin D testing market in Europe. These include Biokit, DIAsource ImmunoAssays S.A, Ortho-Clinical Diagnostics, Biorad Laboratories, Qualigen Inc., City Assays, SCIEX Diagnostics, Dade Behring, Tosoh Bioscience Inc., Becton Dickinson, Piramal Healthcare, Beckman Coulter, and Diazyme Laboratories.

These companies are examined in the report based on several attributes such as business segmentation, geographical segmentation, key business offerings, application overview, revenue generation, and technological advances.

The report also includes a list of tables that gives readers a quantitative understanding of the different segments and components of the vitamin D testing market in Europe.

To order report Call Toll Free: 866-997-4948 or send an email on